ANDEMBRY Solution for injection Ref.[114884] Active ingredients: Garadacimab

Source: European Medicines Agency (EU)  Revision Year: 2025  Publisher: CSL Behring GmbH, Emil-von-Behring-Strasse 76, D-35041 Marburg, Germany

Product name and form

ANDEMBRY 200 mg solution for injection in pre-filled syringe.

ANDEMBRY 200 mg solution for injection in pre-filled pen.

Pharmaceutical Form

Solution for injection.

The solution is a slightly opalescent to clear, brownish-yellow to yellow liquid.

The solution has a pH of approximately 6.1 and an osmolality of approximately 470 mOsm/kg.

Qualitative and quantitative composition

ANDEMBRY 200 mg solution for injection in pre-filled syringe: Each pre-filled syringe contains 200 mg of garadacimab* in 1.2 mL solution.

ANDEMBRY 200 mg solution for injection in pre-filled pen: Each pre-filled pen contains 200 mg of garadacimab* in 1.2 mL solution.

* Garadacimab is a fully human IgG4 monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.

Excipients with known effect: Each pre-filled syringe/pen contains 19.3 mg of proline and 0.24 mg of polysorbate 80.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Garadacimab
List of Excipients

Histidine
Arginine monohydrochloride
Proline
Polysorbate 80 (E433)
Water for injections

Pack sizes and marketing

ANDEMBRY 200 mg solution for injection in pre-filled syringe:

1.2 mL of solution in a pre-filled glass syringe (type I glass) with a bromobutyl stopper, 27G x ½ 5B special thin-walled (STW) staked needle, and is assembled with an extended finger flange and needle safety device.

ANDEMBRY is available as unit packs containing 1 assembled pre-filled syringe and in multipacks containing 3 (3 packs of 1) assembled pre-filled syringes.

ANDEMBRY 200 mg solution for injection in pre-filled pen:

1.2 mL of solution in a pre-filled glass syringe (type I glass) with a bromobutyl stopper, 27G x ½ 5B special thin-walled (STW) staked needle. Each pre-filled syringe is assembled with a pen.

ANDEMBRY is available as unit packs containing 1 assembled pre-filled pen and in multipacks containing 3 (3 packs of 1) assembled pre-filled pens.

Not all pack sizes may be marketed.

Marketing authorization holder

CSL Behring GmbH, Emil-von-Behring-Strasse 76, D-35041 Marburg, Germany

Marketing authorization dates and numbers

EU/1/24/1885/001
EU/1/24/1885/002
EU/1/24/1885/003
EU/1/24/1885/004

Drugs

Drug Countries
ANDEMBRY Lithuania, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.